4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dreyfus, CF; Fulmer, CG; Hempstead, BL; Huang, Y; Stillman, AA; VonDran, MW | 1 |
1 other study(ies) available for 4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol and Clinically Isolated CNS Demyelinating Syndrome
Article | Year |
---|---|
Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination.
Topics: Animals; Astrocytes; Brain-Derived Neurotrophic Factor; Cuprizone; Demyelinating Diseases; Dioxolanes; Disease Models, Animal; Estrogen Antagonists; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelin Proteins; Purines; Receptors, Metabotropic Glutamate; RNA, Untranslated; Signal Transduction; Tamoxifen | 2014 |